
Onconomics Extracts: Natural Substance Testing for Cancer Treatment
Choose the right natural supplements in the fight against cancer
The Onconomics Extracts test provides precise evidence-based insights into the effectiveness of natural substances in destroying cancer cells. Many cancer patients take natural supplements during treatment. This test helps eliminate guesswork by identifying which natural extracts are likely to work against an individual's cancer cells, potentially reducing the use of unnecessary or ineffective supplements.
Onconomics Extracts from RGCC focuses on three key aspects:
- It examines how natural extracts can inhibit the signals that drive cancer cells to grow and multiply.
- It assesses how these extracts can boost the patient’s immune system.
- It provides in-depth information about how such supplements can influence the effectiveness of ongoing cancer treatments.
In addition to analyzing the effectiveness of 50+ natural substances on the patient’s cancer cells, the Onconomics Extracts test provides a Circulating Tumor Cell (CTC) count, quantifying the malignant cells in the patient’s body.
Selected natural substances can play a supportive role in integrative cancer treatment by enhancing the body’s resilience alongside conventional cancer care.
How does the Onconomics Extracts test work?
Onconomics Extracts uses three unique methods to assess how effective natural treatments are at attacking cancer cells.
Using liquid biopsy, the cancer blood test pairs the patient’s circulating tumor cells (CTCs) with a selection of extracts that can be utilized to fight cancer. By analyzing how these extracts interact with each patient’s specific CTCs, we determine which natural supplements are most effective at mitigating the circulation of these tumor cells. The tested natural substances are divided into:
- Class I: Cytotoxic agents
- Class II: Immunostimulants
- Class III: PK inhibitors
The results provide a comprehensive and highly personalized analysis of the most effective natural treatments that patients can use to treat their cancer, to complement conventional cancer care.
For more detailed gene expression analysis, we recommend the Onconomics Extracts+ test, which is an extended version of the Onconomics Extracts test.
The Onconomics Plus test provides a comprehensive evaluation of anti-cancer drugs, gene expression, and natural components, while the Onconomics test focuses exclusively on the effectiveness of anti-cancer drugs.
Who should get an Onconomics Extracts test?
Onconomics Extracts is ideal for cancer patients who want to safely and effectively incorporate natural supplements into their integrative cancer treatment plan. It empowers patients and physicians with personalized data to make informed decisions about natural therapies that can be used alongside conventional treatment.
Test details
Sample type
Blood or tissue sample
(Tissue for CNS Primary Tumors)
Analysis period
≈ 7 business days
Cancer type
Applicable for all cancer types
Final results
7-10 business days after sample delivery
Sample size
15-25 ml of peripheral whole blood.
Tissue sample: Minimum 400mg.
Price*
1550 €
* The prices of the tests may be an issue of local additional taxes and value added taxes which are dependent of each country’s legislation. The prices may vary in areas that are under the jurisdiction of a distributor. These prices are for the tests only, and they do not include in-office fees such as consultation, blood draws, etc.
* RGCC is not liable for any third-party comments or claims regarding our products. For accurate and up-to-date information about our offerings, please refer to our official website: rgcc-international.com
Learn more about natural substance testing for cancer
Use our "intelligent filter" to find out which test is most suitable for your patients.

